BioLife Solutions Price to Free Cash Flow Ratio 2010-2025 | BLFS
Historical price to free cash flow ratio values for BioLife Solutions (BLFS) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| BioLife Solutions Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-29 | 22.32 | 88.50 | |
| 2025-03-31 | 22.84 | $0.25 | 90.56 |
| 2024-12-31 | 25.96 | $0.11 | 229.73 |
| 2024-09-30 | 25.04 | $0.13 | 199.36 |
| 2024-06-30 | 21.43 | $-0.09 | 0.00 |
| 2024-03-31 | 18.55 | $-0.40 | 0.00 |
| 2023-12-31 | 16.25 | $-0.43 | 0.00 |
| 2023-09-30 | 13.81 | $-0.38 | 0.00 |
| 2023-06-30 | 22.10 | $-0.27 | 0.00 |
| 2023-03-31 | 21.75 | $-0.35 | 0.00 |
| 2022-12-31 | 18.20 | $-0.44 | 0.00 |
| 2022-09-30 | 22.75 | $-0.61 | 0.00 |
| 2022-06-30 | 13.81 | $-0.58 | 0.00 |
| 2022-03-31 | 22.73 | $-0.56 | 0.00 |
| 2021-12-31 | 37.27 | $-0.34 | 0.00 |
| 2021-09-30 | 42.32 | $-0.20 | 0.00 |
| 2021-06-30 | 44.51 | $-0.28 | 0.00 |
| 2021-03-31 | 36.00 | $0.15 | 239.68 |
| 2020-12-31 | 39.89 | $0.17 | 230.84 |
| 2020-09-30 | 28.94 | $0.08 | 355.97 |
| 2020-06-30 | 16.35 | $0.19 | 84.41 |
| 2020-03-31 | 9.50 | $-0.01 | 0.00 |
| 2019-12-31 | 16.18 | $0.03 | 586.23 |
| 2019-09-30 | 16.63 | $0.13 | 131.01 |
| 2019-06-30 | 16.95 | $0.10 | 164.56 |
| 2019-03-31 | 17.89 | $0.15 | 119.03 |
| 2018-12-31 | 12.03 | $0.11 | 105.80 |
| 2018-09-30 | 17.50 | $0.12 | 149.70 |
| 2018-06-30 | 11.41 | $0.11 | 108.25 |
| 2018-03-31 | 5.13 | $0.08 | 67.86 |
| 2017-12-31 | 6.00 | $0.03 | 172.41 |
| 2017-09-30 | 5.71 | $-0.10 | 0.00 |
| 2017-06-30 | 2.39 | $-0.18 | 0.00 |
| 2017-03-31 | 2.09 | $-0.28 | 0.00 |
| 2016-12-31 | 1.61 | $-0.44 | 0.00 |
| 2016-09-30 | 1.84 | $-0.50 | 0.00 |
| 2016-06-30 | 1.60 | $-0.55 | 0.00 |
| 2016-03-31 | 1.83 | $-0.59 | 0.00 |
| 2015-12-31 | 2.17 | $-0.52 | 0.00 |
| 2015-09-30 | 2.11 | $-0.52 | 0.00 |
| 2015-06-30 | 1.95 | $-0.46 | 0.00 |
| 2015-03-31 | 1.61 | $-0.31 | 0.00 |
| 2014-12-31 | 1.64 | $-0.36 | 0.00 |
| 2014-09-30 | 2.10 | $-0.21 | 0.00 |
| 2014-06-30 | 2.28 | $-0.14 | 0.00 |
| 2014-03-31 | 3.69 | $-0.15 | 0.00 |
| 2013-12-31 | 8.40 | $-0.02 | 0.00 |
| 2013-09-30 | 11.13 | $0.00 | 0.00 |
| 2013-06-30 | 5.04 | $-0.02 | 0.00 |
| 2013-03-31 | 4.06 | $-0.07 | 0.00 |
| 2012-12-31 | 4.76 | $-0.06 | 0.00 |
| 2012-09-30 | 1.82 | $-0.14 | 0.00 |
| 2012-06-30 | 1.26 | $-0.17 | 0.00 |
| 2012-03-31 | 1.40 | $-0.18 | 0.00 |
| 2011-12-31 | 0.70 | $-0.22 | 0.00 |
| 2011-09-30 | 1.12 | $-0.23 | 0.00 |
| 2011-06-30 | 1.12 | $-0.24 | 0.00 |
| 2011-03-31 | 1.12 | $-0.24 | 0.00 |
| 2010-12-31 | 0.77 | $-0.26 | 0.00 |
| 2010-09-30 | 1.19 | $-0.25 | 0.00 |
| 2010-06-30 | 1.33 | $-0.31 | 0.00 |
| 2010-03-31 | 1.41 | $-0.42 | 0.00 |
| 2009-12-31 | 1.54 | $-0.56 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.062B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.693B | 27.62 |
| Boston Scientific (BSX) | United States | $154.617B | 38.71 |
| Stryker (SYK) | United States | $145.191B | 30.36 |
| EssilorLuxottica (ESLOY) | France | $128.660B | 0.00 |
| Medtronic (MDT) | Ireland | $104.194B | 14.77 |
| Haleon (HLN) | United Kingdom | $50.678B | 28.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.121B | 0.00 |
| ResMed (RMD) | United States | $35.889B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.579B | 15.47 |
| Agilent Technologies (A) | United States | $31.612B | 20.53 |
| Terumo (TRUMY) | Japan | $27.743B | 36.03 |
| Insulet (PODD) | United States | $22.770B | 89.38 |
| Koninklijke Philips (PHG) | Netherlands | $21.553B | 15.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.259B | 11.73 |
| Baxter (BAX) | United States | $15.693B | 11.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.530B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.236B | 21.70 |
| Lantheus Holdings (LNTH) | United States | $5.132B | 12.95 |
| Prestige Consumer Healthcare (PBH) | United States | $4.168B | 18.62 |
| Perrigo (PRGO) | Ireland | $3.726B | 9.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.248B | 14.79 |
| ICU Medical (ICUI) | United States | $3.162B | 23.32 |
| Envista Holdings (NVST) | United States | $3.141B | 26.10 |
| GN Store Nord (GNNDY) | Denmark | $2.200B | 18.22 |
| QuidelOrtho (QDEL) | United States | $2.144B | 14.74 |
| LeMaitre Vascular (LMAT) | United States | $1.830B | 40.91 |
| AtriCure (ATRC) | United States | $1.660B | 0.00 |
| Acuren (TIC) | United States | $1.336B | 0.00 |
| Neogen (NEOG) | United States | $1.326B | 16.97 |
| AdaptHealth (AHCO) | United States | $1.225B | 12.44 |
| Kestra Medical Technologies (KMTS) | United States | $1.174B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.103B | 24.81 |
| Phibro Animal Health (PAHC) | United States | $0.993B | 12.69 |
| InMode (INMD) | Israel | $0.910B | 9.17 |
| CeriBell (CBLL) | United States | $0.621B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.533B | 0.00 |
| Owens & Minor (OMI) | United States | $0.504B | 4.18 |
| Capricor Therapeutics (CAPR) | United States | $0.486B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.325B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.324B | 11.91 |
| Aurora Cannabis (ACB) | Canada | $0.310B | 55.20 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.90 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.14 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.240B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.236B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.207B | 0.00 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.202B | 53.50 |
| Biote (BTMD) | United States | $0.193B | 5.43 |
| Omeros (OMER) | United States | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| High Tide (HITI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.30 |
| Exagen (XGN) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 16.62 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.093B | 0.00 | |
| Fonar (FONR) | United States | $0.089B | 11.48 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.077B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.45 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.74 |
| Safety Shot (SHOT) | United States | $0.026B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |